isoniazid has been researched along with nitazoxanide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, V; Roy, KK; Saxena, AK; Sharma, SK; Singh, S; Srivastava, R | 1 |
| Alvala, M; Chandran, M; Jeankumar, VU; Koushik, PV; Salina, EG; Samala, G; Sriram, D; Yogeeswari, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Constant, P; Daffé, M; Guillet, V; Le, NH; Marrakchi, H; Maveyraud, L; Mourey, L; Nahoum, V; Tranier, S; Verhaeghe, P | 1 |
| Fitzgerald, DW; Johnson, WD; Merveille, YM; Nathan, CF; Ocheretina, O; Pape, JW; Shigyo, K | 1 |
| Gupta, A; Gupta, P; Gupta, UD; Kumar, S; Meena, J; Misra, A; Panda, AK; Sharma, D; Sharma, S | 1 |
1 review(s) available for isoniazid and nitazoxanide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for isoniazid and nitazoxanide
| Article | Year |
|---|---|
Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2011 |
Development of 5-nitrothiazole derivatives: identification of leads against both replicative and latent Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Cell Proliferation; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
Topics: Adenosine Monophosphate; Antitubercular Agents; Drug Evaluation, Preclinical; Humans; Mycobacterium tuberculosis; Salicylanilides; Tuberculosis | 2022 |
Efficacy of nitazoxanide against clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitro Compounds; Sputum; Thiazoles; Tuberculosis, Pulmonary | 2013 |
Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Autophagy; Cell Line; Humans; Isoniazid; Macrophages; Male; Mice; Nitro Compounds; Radiotherapy Planning, Computer-Assisted; Rifabutin; Thiazoles; Tuberculosis | 2016 |